Buradasınız

Farelerde Ağri Eşiği Üzerine Grelinin Etkisi

Effect of Ghrelin on Pain Threshold in Mice

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Objectives: Ghrelin, a novel growth hormone-releasing peptide, was isolated from the rat stomach as an endogenous ligand for the growth hormone secretagogues receptor. The present study was planned to determine whether ghrelin affects pain threshold in mice. Materials and Methods: Adult male BALB/C mice weighing 25-30g were used in this study. The hot plate test was conducted by placing the mouse on a metal surface maintained at 50±0.1°C by using hot plate analgesia meter. The latency to jumping or licking a hind paw was recorded as nociceptive threshold. Animals were allowed to acclimate to the hot plate for a period of 1 week prior to the experiment. Different doses of ghrelin were intraperitoneally administered to the animals after control latencies. Control group received saline alone. Hot plate test were performed in all animals individually in 30 ,60 , 90 and 120 minutes after injection. Pain threshold values were determined and analyzed by Mann-Whitney U Test and Wilkoxon Sign Ranks Test. Results: Ghrelin didn't affect pain threshold throughout the experiment in 0.3pmol and lpmol doses compared to control values. There were significant decreases in pain threshold when it is given in a dose of 3pmol in 30 and 60 minutes (p<0.05 and p<0.01, respectively). Conclusion: The results of this study have presented that ghrelin may have a decreasing effect on pain threshold in mice. Further studies are needed to determine the mechanism by which ghrelin exerts its nociceptive effect. ©2005, Fırat University, Medical School
Abstract (Original Language): 
Amaç: Yeni bir büyüme hormonu salgılatıcı peptit olan grelin, büyüme hormonu salgılatıcı reseptörlerin endojen bir ligandı olarak sıçan midesinden izole edilmiştir. Bu çalışma, grelinin farelerde ağrı eşiği üzerindeki olası etkilerini belirlemek amacıyla planlanmıştır. Gereç ve Yöntem: Çalışmada 25-30 gram ağırlığında yetişkin erkek BALB/C fareler kullanıldı. Hot plate testi, farelerin analjezimetrenin 50±0.1 °C'deki metal yüzeyine bırakıldıkları andan itibaren, ayaklarını hızla çırptıkları veya yaladıkları süre saniye olarak ağrı eşiği değeri için kaydededilerek uygulandı.. Deneylerden önce hayvanlar 1 hafta süreyle hot plate's alıştırıldı. Deney günü, analjezimetrede kontrol kayıtlan alındıktan hemen sonra, intraperitoneal yolla farlı dozlardaki grelin uygulamaları yapıldı. Kontrol grubuna serum fizyolojik verildi. Bütün hayvanlara enjeksiyonlardan 30, 60, 90 ve 120 dakika sonra test uygulandı. Ağrı eşiği değerleri belirlendi ve Mann-Whitney U Testve Wilkoxon Sign Ranks Test kullanılarak analiz edildi. Bulgular: Grelin kontrol grubuyla karşılaştırıldığında 0.3 pmol ve 1 pmol dozlarında ağrı eşiğini etkilemedi. 3 pmol dozda ise, 30. ve 60. dakikalarda ağrı eşiğinde belirgin azalmalar ortaya çıktı (p<0.05 ve p<0.01). Sonuç: Bu çalışmanın sonuçları grelinin farelerde ağrı eşiğini düşürdüğünü göstermektedir. Grelinin bu hiperaljezik etkisinin mekanizmasını belirlemek için ek çalışmalara ihtiyaç vardır. ©2005, Fırat Üniversitesi, Tıp Fakültesi
89-91

REFERENCES

References: 

1. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-60.
2. Arvat E, Di Vito L, Broglio F, et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000; 23:493-5.
3. Date Y, Murakami N, Kojima M, et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 2000; 275: 477-80.
4. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-13.
5. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-8.
6. Lu S, Guan JL, Wang QP, et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 2001; 321: 157-60.
7. Guan XM, Yu H, Palyha OC, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23-9.
8. Lin Y, Matsumura K, Fukuhara M, et al. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 2004; 43: 977-82.
9. Carlini VP, Monzon ME, Varas MM, et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 2002; 299: 739-43.
10. Weikel JC, Wichniak A, Ising M, et al. Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab 2003; 284:407-15.
11. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004; 89: 1630-5.
12. Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIAforthe active form of ghrelin. Endocrinol 2002; 143: 3341-50.
13. Glavaski-Joksimovie A, Jeftinija K, Scanes CG, Anderson LL, Jeftinija S. Stimulatory effect of ghrelin on isolated porcine somatotropes. Neuroendocrinol 2003; 77: 367-79.
14. Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003; 52: 948-56.
15. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71: 1-51
16. Bajic D, VanManh Hoang Q, Nakajima S, Nakajima Y. Dissociated histaminergic neuron cultures from the tuberomammillary nucleus of rats: culture methods and ghrelin effects. J Neurosci Met 2004; 132: 177-84.
17. Glick SD, Crane LA. Opiate-like and abstinence-like effects of intracerebral histamine administration in rats. Nature 1978; 273: 547-9.
18. Thoburn KK, Hough LB, Nalwalk JW, Mischler SA. Histamine-induced modulation of nociceptive responses. Pain 1994; 58: 29¬37.
19. Chung YH, Miyake H, Kamei C, Tasaka K. Analgesic effect of histamine induced by intracerebral injection into mice. Agents Actions 1984; 15: 137-42.
20. Malmberg-Aiello P, Lamberti C, Ghelardini C, Giotti A, Bartolini ARole of histamine in rodent antinoci cepti on. Br J Pharmacol 1994; 111: 1269-79.
21. Lamberti C, Bartolini A, Ghelardini C, Malmberg-Aiello P. Investigation into the role of histamine receptors in rodent antinociception. Pharmacol Biochem Behav 1996; 3: 567-74.
22. Andersen E, Dafny N. An ascending serotonergic pain modulation pathway from the dorsal raphe nucleus to the parafascicularis nucleus of the thalamus. Brain Res 1983; 269: 57-67.
23. Brunetti L, Recinella L, Orlando G, et al. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 2002; 454: 189-92
24. Carlini VP, Varas MM, Cragnolini AB, et al. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun 2004; 313: 635-41.

Thank you for copying data from http://www.arastirmax.com